Fundraising Fox
/Companies
Sign in

Innoblative

Chicago, US · Founded 2013 · 3 known investors

Find your way into Innoblative

Sign up to find every way you can get introduced to Innoblative

  • Your email: who you already know at Innoblative, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Innoblative team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Innoblative Designs develops a medical device for breast-conserving therapy, focused on treating breast cancer during surgical procedures. The company operates in the medtech sector.

Medical Devices

Founders & leadership

Innoblative was founded in 2013 by Tyler Wanke.

TWTyler Wanke
Tyler WankeCo-Founder, Board Member, Investor

Investors · 3

Bascom Ventureslisted by Bascom VenturesBoston

How we know: Bascom Ventures's portfolio page · Not right? Tell us

Boston Harbor Angelslisted by Boston Harbor AngelsBoston · $250K – $1.5M

How we know: Boston Harbor Angels's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$9.4M disclosed across 3 rounds · 2014–2017

▶$7.2MraisedOct 2019 · 37 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Kelly LondyExecutive Officer, Director
  • Tyler WankeDirector
  • Dianne BlancoDirector
  • Matthew SteinmetzDirector
  • Gintaras VaisnysDirector
Offering amount
$7.2M
Amount sold
$7.2M
Minimum investment
$20K
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedApr 2016 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Arthur HoldenDirector
  • Matthew SteinmetzDirector
  • Dianne BlancoDirector
  • Gintaras VaisnysDirector
  • Tyler WankeExecutive Officer, Director
Offering amount
$1M
Amount sold
$1M
Minimum investment
$25K
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJan 2016 · 21 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tyler WankeExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
Minimum investment
$5K
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Abingdon HealthAbingdon Health is a contract developer and manufacturer of rapid lateral flow diagnostic tests, serving healthcare, animal health, and plant health sectors. It provides services from biomarker validation through FDA submission, scale-up, and large-scale manufacturing, and also supplies its own lateral flow test brands to consumers, retail, wholesale, and distributors globally.

Companies working in the same space as Innoblative.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase IISTTR2017$486.2K
National Science FoundationPhase ISTTR2016$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Innoblative do?
Innoblative Designs develops a medical device for breast-conserving therapy, focused on treating breast cancer during surgical procedures. The company operates in the medtech sector.
Who founded Innoblative?
Innoblative was founded by Tyler Wanke in 2013.
Who are Innoblative's investors?
Innoblative's investors include Alumni Ventures, Bascom Ventures, Boston Harbor Angels.
How much funding has Innoblative raised?
Innoblative has disclosed $9.4M raised across 3 rounds.
Where is Innoblative headquartered?
Innoblative is headquartered in Chicago, US.